Skip to main content
. Author manuscript; available in PMC: 2009 Aug 24.
Published in final edited form as: Am J Transplant. 2009 Apr;9(4):812–819. doi: 10.1111/j.1600-6143.2009.02555.x

Table 2.

Histopathology and C4d staining of biopsies

Biopsy findings C4d staining Total
(n=368)
P value
Diffuse(n=35) Focal(n=77) Negative(n=256)
Normal 2 (5.5%) 4(5.1%) 22(8.6%) 28(7.6%) 0.56
All ACR 12(40%) 38(49.4%) 61(23.8%)* 111(30.2%) <0.001
  IA/IB 12(34.2%) 24(31.2%) 47(18.4%) 83(22.5%) 0.01
  IIA/IIB 2 (5.7%) 13(16.8%) 13(5%) 28(7.6%) 0.01
  III 0(0%) 1 (1.3%) 1(0.4%) 2(0.4%) 0.57
Borderline 2(5.7%) 4(5.1%) 10(3.3%) 16(4.3%) 0.81
Plasma cell rich infiltrate 3(8.5%) 3(5.7%) 9(4.9%) 15(4.1%) 0.49
Glomerular diseases 5(14.3%) 9(11.7%) 43(16.8%) 57(15.5%) 0.54
Transplant Glomerulopathy 7(20%) 4(5.1%)* 14(5.4%)* 25(6.7%) 0.01
IF/TA 2(5.7%) 17(22%) 42(16.4%) 61(16.5%) 0.11
CNI toxicity 5(14.3%) 10(13.1%) 56(21.8%) 71(19.3%) 0.16
ATI 0(0%) 4(5.1%) 26(10.0%) 30(8.3%) 0.08
AIN 3(8.5%) 4(5.1%) 25(9.8%) 32(8.7%) 0.45
Interstitial hemorrhage 3(8.5%) 2(2.6%) 3(1.2%)* 8(2.1%) 0.02
Capillaritis 22(62.9%) 45(58.4%) 68(26.6%)* 135(36.7%) <0.001
Glomerulitis 20(57.1%) 26(33.8%)* 46(18%)* 92(25%) <0.001

ACR: acute cellular rejection, IF/TA: interstitial fibrosis/ tubular atrophy, CNI: calcineurin inhibitor, ATI: acute tubular injury, AIN: acute interstitial nephritis

*

Significantly less in these groups